Publications
5674 Results
- Journal / Conference
- Journal of Thoracic Oncology, 6(1):115-120;
- Year
- 2011
- Research Committee(s)
- Lung
- Study Number(s)
- SWOG-9308, SWOG-9509
Comparison of platinum based chemotherapy in patients older and younger than 70 years of age: an analysis of Southwest Oncology Group trials 9308 and 9509 [PMID21107287; PMC3075557]
- Journal / Conference
- Annals of Oncology, 22(12):2610-2615;
- Year
- 2011
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- S0413
Southwest Oncology Group Study S0413: a phase II trial of GW572016 (lapatinib) as first line therapy in patients with advanced or metastatic gastric cancer [PMID21415234;PMC3221514]
- Journal / Conference
- Cancer Chemotherapy and Pharmacology 68(6):1595-602; 2011 May 20 [Epub ahead of print];
- Year
- 2011
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- S0202
A phase II trial of gemcitabine and capecitabine in patients with unresectable or metastatic gallbladder cancer or cholangiocarcinoma: Southwest Oncology Group study S0202
- Journal / Conference
- Journal of the National Cancer Institute 103(20):1498-1506; JAMA
- Year
- 2011
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- SWOG-9415 (INT-0153) (CALGB-9498) (ECOG-S9415) (NCCTG-S9415)
Outcomes among black patients with stage II/III colon cancer receiving adjuvant chemotherapy: an accent group analysis [PMID21997132; PMC3196480]
- Journal / Conference
- Cancer Cause and Control 22(8):1121-1131;
- Year
- 2011
- Research Committee(s)
- Cancer Control
- Study Number(s)
- SWOG-9217
Serum estrogen levels and prostate cancer risk in the Prostate Cancer Prevention Trial: a nested case-control study. PMID 21667068; PMC3139891
- Journal / Conference
- Journal of Clinical Oncology 29:(suppl 4: abstr 2); ASCO GI Cancers Symposium 2011, oral presentation
- Year
- 2011
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- S0356
Excision repair cross-complementation group 1 (ERCC1) gene expression (GE) is associated with outcome in stage II-III esophageal adenocarcinoma (EA) patients treated with preoperative platinum-based chemoradiation (CRT) in a phase II cooperative study (SWOG 0356)
- Journal / Conference
- Journal of Thoracic Oncology, Nov; 6(11):1938-1945;
- Year
- 2011
- Research Committee(s)
- Lung
- Study Number(s)
- S0509
Phase II study of Cediranib in patients with malignant pleural mesothelioma: SWOG S0509 [PMID21964533;PMC3477852]
- Journal / Conference
- Journal of Thoracic Oncology 6(3):598-601;
- Year
- 2011
- Research Committee(s)
- Lung
- PMID
- PMID21270668
- PMC
- PMC3643692
A practical guide of the Southwest Oncology Group to measure malignant pleural mesothelioma (MPM) tumors by RECIST and modified RECIST criteria
- Journal / Conference
- American Association for Cancer Research 2011 Annual Meeting, accepted (poster);
- Year
- 2011
- Research Committee(s)
- Breast
- Study Number(s)
- S0221
Effect of physician recommendation on multivitamin and antioxidant supplement use during chemotherapy in an adjuvant trial for breast cancer (SWOG S0221)
- Journal / Conference
- Cancer Prevention Research 4(11):1761-1769;
- Year
- 2011
- Research Committee(s)
- Genitourinary
- Study Number(s)
- S9917